<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2241</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>PHYSICIANS PRESCRIBING PATTERNS OF ORAL ANTIDIABETIC DRUGS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>D</surname><given-names>Sreedhar</given-names></name></contrib><contrib contrib-type="author"><name><surname>SL</surname><given-names>Virendra</given-names></name></contrib><contrib contrib-type="author"><name><surname>J</surname><given-names>Manthan</given-names></name></contrib><contrib contrib-type="author"><name><surname>P</surname><given-names>Ajay</given-names></name></contrib><contrib contrib-type="author"><name><surname>N</surname><given-names>Prashanth M Udupa</given-names></name></contrib></contrib-group><volume/><issue/><fpage>32</fpage><lpage>42</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Physicians prescribing pattern of oral antidiabetic drugs may be key to avoid the serious complications of patients suffering from type 2 diabetes. However, fixed dose combinations were often prescribed to achieve target glycemic levels. Treatment complexity can be reduced by prescribing a fixed dose combination of two or more oral antidiabetic drugs. There are good numbers of studies which suggest the use of fixed dose combinations not only to reduce the complications of diabetes but also to improve adherence. A variety of fixed dose combination oral antidiabetic drugs in different dosage strengths are available and the strategies for selecting such fixed dose combinations options depends on physicians prescribing behavior and patients condition. This article describes the increasing preference of physicians to prescribe fixed dose combinations of oral antidiabetic drugs.&#13;
</p></abstract><kwd-group><kwd>Fixed dose combinations</kwd><kwd> oral antidiabetic drugs</kwd><kwd> physicians prescribing pattern.</kwd></kwd-group></article-meta></front></article>
